trial

Vaping and Smoking Project in People With Schizophrenia

NCTId NCT06944847
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 64 (estimated)
Sponsored by State University of New York at Buffalo
Primary completion 2027-04-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
64 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
None
Start
2025-02-15
Primary completion
2027-04-01
Eligibility
ALL · 21 Years · 50 Years

Interventions & indications

Drugs
Acute (24-hour) abstinenceAd libitum smoking/vaping

Sponsors

State University of New York at BuffaloLead Sponsor
Roswell Park Cancer InstituteCollaborator
National Institute on Drug Abuse (NIDA)Collaborator

Investigators

1
Larry Hawk, PhDPrincipal Investigator

Sites

1 total
Buffalo, United States

Facts & assertions

4 sourced
Enrollment
64
Phase
NA
Primary Completion Date
2027-04-01
Status
RECRUITING
relationships
The graph out of here
drug
Acute (24-hour) abstinence
drug
Ad libitum smoking/vaping
drug
lead_sponsor
State University of New York at Buffalo
company
collaborator
Roswell Park Cancer Institute
company
National Institute on Drug Abuse (NIDA)
company
indication
Acute Abstinence From Cigarettes vs E-cigarettes (ENDS)
indication
investigator
Larry Hawk, PhD
person